Evidence map›Paper›PMID 37490324›Full record

ArticleeLife2023

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.

Anna Castano, Margaux Silvestre, Carrow I Wells, Jennifer L Sanderson, Carla A Ferrer, Han Wee Ong, Yi Lang, William Richardson, Josie A Silvaroli, Frances M Bashore and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Role of the CDKL1-SOX11 signaling axis in acute kidney injury.American journal of physiology. Renal physiology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Illumination of understudied ciliary kinases.Frontiers in molecular biosciences · 2024
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Anna Castano *Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States.
Margaux Silvestre *Kinases and Brain Development Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID https://orcid.org/0000-0003-1377-477X
Carrow I WellsStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.ORCID https://orcid.org/0000-0003-4799-6792
Jennifer L SandersonDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, United States.
Carla A FerrerStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Han Wee OngStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Yi LangStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
William RichardsonCentre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Josie A SilvaroliDivision of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, United States.
Frances M BashoreStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.ORCID https://orcid.org/0000-0003-4241-9873
Jeffery L SmithStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.ORCID https://orcid.org/0000-0003-2189-0420
Isabelle M GenereuxStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Kelvin DempsterKinases and Brain Development Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID https://orcid.org/0009-0009-0750-0175
David H DrewryStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Navlot S PablaDivision of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, United States.ORCID https://orcid.org/0000-0001-9408-0539
Alex N BullockCentre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Tim A BenkeDepartments of Pediatrics, Pharmacology, Neurology and Otolaryngology, University of Colorado School of Medicine, Aurora, United States.ORCID https://orcid.org/0000-0002-6969-5061
Sila K UltanirKinases and Brain Development Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID https://orcid.org/0000-0001-5745-3957
Alison D AxtmanStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
University of North Carolina at Chapel Hill · USThe Francis Crick Institute · GBUniversity of Colorado Denver · USDiscovery Centre · CAThe Ohio State University · US

Funding

Illuminating Function of the Understudied Druggable KinomeU24DK116204 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSON, GARY L. · 2017 to 2022
$13.6M
Tools for Accelerating R&D for Historically Understudied Protein KinasesR44TR001916 · NCATS · LUCEOME BIOTECHNOLOGIES, LLC · PI ZUTSHI, REENA · 2017 to 2018
$1.4M
Pilot studies to characterize CDKL5 inhibitorsR21NS112770 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BENKE, TIMOTHY A · 2020 to 2020
$444k
Cancer Research UK CC2037Medical Research Council CC2037NCATS NIH HHS R44 TR001916NIDDK NIH HHS U24 DK116204NIH HHS R44TR001916NIH HHS U24DK116204NINDS NIH HHS NS112770NINDS NIH HHS R21 NS112770Wellcome Trust CC2037
6 · The paper itself

Abstract

Pathological loss-of-function mutations in cyclin-dependent kinase-like 5 (

Indexed as

HippocampusProtein Serine-Threonine KinasesAnimalsCyclin-Dependent KinasesEpileptic SyndromesGlycogen Synthase Kinase 3 betaHumansMiceMice, KnockoutSpasms, InfantileCDKL5 protein, humanCDKL5 protein, mouseCyclin-Dependent KinasesGlycogen Synthase Kinase 3 betaProtein Serine-Threonine KinasesCDKL5GSK3hippocampusLTPneuroscienceprotein kinaserat

Identifiers

PMID37490324
PMCPMC10406435
OpenAlexW4385230232

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.